Showing 41 - 50 of 76,036
In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …
Persistent link: https://www.econbiz.de/10012472804
Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...
Persistent link: https://www.econbiz.de/10012469083
Persistent link: https://www.econbiz.de/10012514677
Persistent link: https://www.econbiz.de/10011634081
This paper contributes to a better understanding of the relationship between strategic alliances and VC exits. Recent empirical literature concludes that strategic alliances improve the probability of successful exits (IPOs and M&As) for venture-backed companies. When we control for observed and...
Persistent link: https://www.econbiz.de/10012902098
Reputation-based trust, reflecting the time-dependency of trust, influences inter-firm alliances. A literature review resulted in hypotheses which were tested in an empirical study based on a quantitative analysis and in-depth interviews with firms in the bio tech sector of human health in the...
Persistent link: https://www.econbiz.de/10014027008
Studies strategic alliances between small and large North American biotechnology firms. A strategic alliance (SA) is … executives of selected North American companies: 42 out of 144 dedicated biotechnology companies (DBCs) and 21 out of 70 large … biotechnology firms responded. Additionally, in-depth interviews with some 30 large and small companies investigated SA networks …
Persistent link: https://www.econbiz.de/10013070604
Persistent link: https://www.econbiz.de/10013165964
In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …
Persistent link: https://www.econbiz.de/10013224324
Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...
Persistent link: https://www.econbiz.de/10013233843